Explainable haemoglobin deferral predictions using machine learning models: Interpretation and consequences for the
Marieke Vinkenoog1,2, Matthijs van Leeuwen2, Mart P Janssen1
1Department of Donor Medicine Research, Sanquin Research, Amsterdam, the Netherlands.
Vox Sanguinis
|September 14, 2022
Summary
This study developed an explainable model to predict hemoglobin deferral in blood donors. Implementing this model can decrease deferral rates by 60% and improve blood supply management.
Area of Science:
- Biomedical Science
- Data Science
- Public Health
Background:
- Accurate prediction of hemoglobin (Hb) deferral is crucial for blood banks to optimize efficiency and donor retention.
- Complex predictive models are necessary for accuracy but require explainability for practical implementation.
- Estimating the impact of prediction models on blood supply is essential to prevent shortages before deployment.
Purpose of the Study:
- To develop an explainable model for predicting hemoglobin deferral in whole-blood donors.
- To assess the model's impact on blood supply by simulating earlier or later donation invitations.
- To reduce deferral rates and enhance blood bank operational efficiency.
Main Methods:
- Utilized donation visit data (Oct 2017-Dec 2021) including donor demographics, donation history, and ferritin levels.
- Employed Support Vector Machines for prediction and SHapley Additive exPlanations for model interpretability.
- Assessed model performance using precision and recall, and estimated blood supply impact.
Main Results:
- A novel, explainable model for predicting Hb deferral was developed.
- Application of the model could lead to 64% of non-deferred donors being invited earlier and 80% of deferred donors later.
- Predicted a 60% reduction in deferral rates, with specific impacts on female and male donors.
Conclusions:
- The developed model effectively predicts Hb deferral with high explainability.
- Implementing this model is projected to increase blood bank visits by 15% while significantly decreasing deferral rates.
- This approach offers a pathway to improve blood supply management and donor engagement.
Related Concept Videos
Blood Transfusion and Agglutination
11.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.1K
Blood Transfusion
772
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
772
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
139
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
139
Oxygen Transport in the Blood
3.1K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
3.1K
Hemoglobin
4.1K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
4.1K
Factors Affecting Erythropoiesis
3.6K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.6K


